Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Treatment-Induced Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Not applicableStudy completedNCT04609891
What this trial is testing

Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors

Who this might be right for
Thrombocytopenia
Anhui Provincial Cancer Hospital 74
Testing effectiveness (Phase 2)UnknownNCT04797182
What this trial is testing

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Who this might be right for
ThrombocytopeniaCytarabine Causing Adverse Effects in Therapeutic UseLymphoma
Sun Yat-sen University 46
Testing effectiveness (Phase 2)Looking for participantsNCT06898983
What this trial is testing

Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia

Who this might be right for
Cancer Treatment-induced Thrombocytopenia (CTIT)
Anhui Provincial Hospital 97
Testing effectiveness (Phase 2)Ended earlyNCT00926354
What this trial is testing

Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients

Who this might be right for
Chemotherapy Induced Thrombocytopenia
BioMAS Ltd 40
Large-scale testing (Phase 3)Looking for participantsNCT06456528
What this trial is testing

QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia

Who this might be right for
Cancer Treatment-Induced Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 235
Large-scale testing (Phase 3)Looking for participantsNCT06759636
What this trial is testing

A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11

Who this might be right for
CTIT: Cancer Therapy Induced Thrombocytopenia
The First Affiliated Hospital with Nanjing Medical University 88
Testing effectiveness (Phase 2)Study completedNCT00413283
What this trial is testing

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerChemotherapy-Induced ThrombocytopeniaNon-Small Cell Lung Cancer+5 more
Amgen 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05944211
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid Leukemia

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
RenJi Hospital 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07334093
What this trial is testing

Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

Who this might be right for
Cancer Therapy-induced Thrombocytopenia (CTIT)
Sun Yat-sen University 204
Testing effectiveness (Phase 2)Looking for participantsNCT07257809
What this trial is testing

Herombopag Treated T-DM1 Induced Platelet Reduction

Who this might be right for
Thrombocytopenia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 56
Testing effectiveness (Phase 2)Study completedNCT01147809
What this trial is testing

Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 130
Testing effectiveness (Phase 2)UnknownNCT05672420
What this trial is testing

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

Who this might be right for
Hematologic NeoplasmsNeutropeniaAnemia+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 181
Testing effectiveness (Phase 2)UnknownNCT06433830
What this trial is testing

Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy

Who this might be right for
ThrombocytopeniaRadiotherapy Side Effect
Sir Run Run Shaw Hospital 50
Post-approval studies (Phase 4)UnknownNCT05411705
What this trial is testing

Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury

Who this might be right for
Cancer Treatment Induced Thrombocytopenia
The First Affiliated Hospital of Dalian Medical University 165
Testing effectiveness (Phase 2)Study completedNCT00283439
What this trial is testing

A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

Who this might be right for
Chemotherapy-Induced ThrombocytopeniaHodgkin's LymphomaNon-Hodgkin's Lymphoma+3 more
Amgen 39
Testing effectiveness (Phase 2)Looking for participantsNCT07441720
What this trial is testing

Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)

Who this might be right for
ThrombocytopeniaCancer Treatment-induced Thrombocytopenia
Zhejiang Cancer Hospital 25
Testing effectiveness (Phase 2)Ended earlyNCT03622931
What this trial is testing

Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines

Who this might be right for
Ovarian Cancer
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21
Large-scale testing (Phase 3)Active Not RecruitingNCT03937154
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 145
Testing effectiveness (Phase 2)Ended earlyNCT03195010
What this trial is testing

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+11 more
Fred Hutchinson Cancer Center 4